Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

Trump's sweeping tariff measures have shaken the global economy, though, leaving many investors nursing huge losses.

Mobico shares today skidded 21% after the National Express owner announced the sale of its North American school bus ...

Circulating levels of beta in France has been cited as the reason for ... according to Sanofi and GSK estimates. Kineret reviewed COVID-related respiratory failure News of the Vidprevtyn review ...

France, long recognized as a global leader in cosmetic innovation and export, plays a pivotal role in the retinoid market. The French retinoid industry is growing at the fastest pace in Europe, with a ...